Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Avery W. Catlin currently holds 4,350 shares of Provention Bio, Inc. (PRVB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Avery W. Catlin has been a net seller of PRVB stock. They have purchased $219.5K and sold $5.6M worth of shares.
Avery W. Catlin's most recent insider trade was on May 30, 2024, when they sold 2,783 shares at $0.00 per share.
Avery W. Catlin serves as Executive at Provention Bio, Inc. (PRVB). They have executed 37 insider transactions totaling $5.8M over their tenure at the company.
Avery W. Catlin holds the position of Executive at Provention Bio, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Avery W. Catlin has shown a selling trading pattern, with $219.5K in total purchases and $5.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Avery W. Catlin was on Dec 6, 2013, when they sold $4.5M worth of CLDX shares. This transaction involved 183,333 shares at $24.50 per share.
Avery W. Catlin currently owns 4,350 shares of Provention Bio, Inc. (PRVB), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Avery W. Catlin's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Avery W. Catlin has 37 Form 4 filings on record as an insider at Provention Bio, Inc..
Set alerts for Avery W. Catlin and 40,000+ other insiders.